Stay updated on Anti-PD-1 Antibody With HD IL-2 in Metastatic Melanoma Clinical Trial
Sign up to get notified when there's something new on the Anti-PD-1 Antibody With HD IL-2 in Metastatic Melanoma Clinical Trial page.

Latest updates to the Anti-PD-1 Antibody With HD IL-2 in Metastatic Melanoma Clinical Trial page
- Check7 days agoChange DetectedRemoved a small set of related-topic link text (including “Melanoma” and MedlinePlus Genetics) from the study page.SummaryDifference0.2%

- Check14 days agoChange DetectedMelanoma was added to the related topics and MedlinePlus Genetics was added under related terms. The revision history shows the page version updated to v3.5.2 (replacing v3.5.0).SummaryDifference0.2%

- Check21 days agoChange DetectedMelanoma was removed from the conditions section and MedlinePlus Genetics was removed from related topics.SummaryDifference0.2%

- Check43 days agoChange DetectedRevision notes updated: added Revision v3.5.0 and removed Revision v3.4.3.SummaryDifference0.1%

- Check50 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check57 days agoChange DetectedAdded related topics: Melanoma and MedlinePlus Genetics.SummaryDifference0.2%

Stay in the know with updates to Anti-PD-1 Antibody With HD IL-2 in Metastatic Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Anti-PD-1 Antibody With HD IL-2 in Metastatic Melanoma Clinical Trial page.